Hu Zhou

727 total citations
44 papers, 240 citations indexed

About

Hu Zhou is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Hu Zhou has authored 44 papers receiving a total of 240 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 15 papers in Genetics and 10 papers in Immunology. Recurrent topics in Hu Zhou's work include Platelet Disorders and Treatments (18 papers), Blood groups and transfusion (8 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Hu Zhou is often cited by papers focused on Platelet Disorders and Treatments (18 papers), Blood groups and transfusion (8 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Hu Zhou collaborates with scholars based in China, Italy and Canada. Hu Zhou's co-authors include Renchi Yang, Yongping Song, Zeping Zhou, Huiyuan Li, Keshu Zhou, Li Ma, Lei Zhang, Jian Zhou, Donglei Zhang and Linlin Li and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Hu Zhou

38 papers receiving 239 citations

Peers

Hu Zhou
Claire Petry Switzerland
Juan Esteban García-Robledo United States
Kerry Taylor United States
Tamara Berno Italy
Ilaria Silvestris Italy
Carlos Hader United States
Sophia Balderman United States
Zvenyslava Husak Austria
Francesco Autore Italy
Katerina Pyrovolaki Greece
Claire Petry Switzerland
Hu Zhou
Citations per year, relative to Hu Zhou Hu Zhou (= 1×) peers Claire Petry

Countries citing papers authored by Hu Zhou

Since Specialization
Citations

This map shows the geographic impact of Hu Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hu Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hu Zhou more than expected).

Fields of papers citing papers by Hu Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hu Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hu Zhou. The network helps show where Hu Zhou may publish in the future.

Co-authorship network of co-authors of Hu Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Hu Zhou. A scholar is included among the top collaborators of Hu Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hu Zhou. Hu Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xue, Feng, Tienan Zhu, Zeping Zhou, et al.. (2025). Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials. Nature Medicine. 32(1). 93–102.
2.
Wang, Zhihong, Qi Yan, Ping Lu, et al.. (2025). Deep learning HRNet FCN for blood vessel identification in laparoscopic pancreatic surgery. npj Digital Medicine. 8(1). 235–235. 1 indexed citations
3.
4.
Li, Mengjuan, Xuewen Song, Yuanyuan Zhang, et al.. (2025). A Case Series and Literature Review on Zanubrutinib Therapy for the Treatment of Relapsed/Refractory Immune Thrombocytopenia. Cancer Reports. 8(2). e70152–e70152. 2 indexed citations
5.
Xu, Min, Jing-Ming Guo, Yuping Gong, et al.. (2024). Zuberitamab, an innovative anti-CD20 monoclonal antibody, for patients with primary immune thrombocytopenia in China: a randomized, double-blind, placebo-controlled, phase 2 study. The Lancet Regional Health - Western Pacific. 47. 101096–101096. 1 indexed citations
6.
7.
Fu, Rongfeng, H. Dong, Donglei Zhang, et al.. (2023). Clinical features and current treatment status of essential thrombocythemia in older adults: a multicenter real-world study in China. Annals of Hematology. 102(8). 2097–2107. 1 indexed citations
8.
Liu, Wei, Feng Xue, Rongfeng Fu, et al.. (2023). Preclinical studies of a factor X activator and a phase 1 trial for hemophilia patients with inhibitors. Journal of Thrombosis and Haemostasis. 21(6). 1453–1465. 4 indexed citations
9.
10.
Liu, Chengyuan, et al.. (2023). Clinical value of the systemic immune-inflammation index in moyamoya disease. Frontiers in Neurology. 14. 1123951–1123951. 15 indexed citations
11.
Zhang, Wenhui, Man‐Chiu Poon, Runhui Wu, et al.. (2022). Factor IX inhibitors in haemophilia B: A report of National Haemophilia Registry in China. Haemophilia. 29(1). 123–134. 6 indexed citations
12.
Han, Lu, Jishuai Zhang, Jian Zhou, et al.. (2021). Single VHH-directed BCMA CAR-T cells cause remission of relapsed/refractory multiple myeloma. Leukemia. 35(10). 3002–3006. 33 indexed citations
13.
14.
15.
Zhou, Keshu, Qing Zhang, Yanyan Liu, et al.. (2017). Aberrant histone modification in CD19<sup>+</sup> B cells of the patients with chronic lymphocytic leukemia. OncoTargets and Therapy. Volume 10. 1173–1179. 5 indexed citations
16.
Zhou, Hu, Zeping Zhou, Xin Huang, et al.. (2012). Telomerase Activity Increased and Telomere Length Shortened in Peripheral Blood Cells from Patients with Immune Thrombocytopenia. Journal of Clinical Immunology. 33(3). 577–585. 6 indexed citations
17.
Zhou, Hu, Rongfeng Fu, Hongmei Wang, et al.. (2012). Immune thrombocytopenia in the elderly: clinical course in 525 patients from a single center in China. Annals of Hematology. 92(1). 79–87. 20 indexed citations
18.
Zhou, Hu, Huiyuan Li, Li Ma, et al.. (2011). CD72 gene expression in immune thrombocytopenia. Platelets. 23(8). 638–644. 7 indexed citations
19.
Ma, Li, Zeping Zhou, Hongmei Wang, et al.. (2011). Increased expressions of DNA methyltransferases contribute to CD70 promoter hypomethylation and over expression of CD70 in ITP. Molecular Immunology. 48(12-13). 1525–1531. 16 indexed citations
20.
Pei, Dong‐Sheng, et al.. (2005). Cys74 and Cys163 are necessary for IL-18 to elicit IFN-γ production from peripheral blood lymphoid mononuclear cells. Molecular Immunology. 42(11). 1367–1373. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claire Petry Breakdown of academic impact, for papers by Juan Esteban García-Robledo Breakdown of academic impact, for papers by Kerry Taylor Breakdown of academic impact, for papers by Tamara Berno Breakdown of academic impact, for papers by Ilaria Silvestris Breakdown of academic impact, for papers by Carlos Hader Breakdown of academic impact, for papers by Sophia Balderman Breakdown of academic impact, for papers by Zvenyslava Husak Breakdown of academic impact, for papers by Francesco Autore Breakdown of academic impact, for papers by Katerina Pyrovolaki
Rankless by CCL
2026